home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

A Rare Look into New Guidances: The Future State of Orphan Drug Development

 
  January 30, 2025  
     
 
Xtalks, Online
2025-02-25


Rare disease drug development is evolving, driven by innovation and regulatory advancements. With many devastating rare diseases still lacking approved treatments, regulatory agencies are taking significant steps to support innovators, advance research and improve patient outcomes. Through updated and newly developed guidances, they aim to provide a roadmap for navigating the complexities of this specialized field.

In this webinar, they will highlight key regulatory guidances published within the past year, addressing artificial intelligence (AI), accelerated approval pathways and fostering diversity, equity and inclusion (DEI) in clinical research. Attendees will gain insights into the challenges these guidances aim to address, their potential to transform the rare disease landscape, and strategies for incorporating any necessary changes into drug development programs.

Register for this webinar to explore how the rare disease landscape is changing with guidance from AI, accelerated approval pathways and fostering DEI in clinical research.

Keywords: Drug Development, Clinical Research, CRO, Drug Manufacturing,  Oncology Drugs, Clinical Data, Therapeutic Areas, Oncology Drug Development, Rare Diseases/Orphan Drugs
 
 
Organized by: Xtalks
Invited Speakers: Adam Bloomfield, MD, FAAP, Vice President, General Medicine, Rare Disease and Pediatrics, Medical Affairs, Premier Research
Leslie Wetherell, Executive Director, Program Strategy, Rare Disease and Pediatrics, Premier Research
Paulla Dennis, Executive Director, Program Strategy, Rare Disease, Pediatrics, Cell and Gene Therapy, Premier Research
 
Deadline for Abstracts: 2025-02-25
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2025 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.